AF
Ami Fadia Needham Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
117
Avg Return
Past Year
Past Year
11%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
87%
Neutral
13%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $304 |
23%
upside
| 3 | +33% |
0
%
| 5 Dec ‘25 10 hours ago |
|
|
|
Buy
Reiterated
| $42 |
8%
upside
| 2 | +2.1% |
0
%
| 24 Nov ‘25 11 days ago |
|
|
|
Buy
Reiterated
| $16 |
99%
upside
| 1 | -4.9% |
0
%
| 24 Nov ‘25 11 days ago |
|
|
|
Buy
Maintained
| $72 |
9%
downside
| 2 | +8.8% |
0
%
| 6 Nov ‘25 29 days ago |
|
|
|
Buy
Maintained
| $29 |
6%
upside
| 2 | +8.7% |
0
%
| 6 Nov ‘25 29 days ago |
|
|
|
Buy
Reiterated
| $154 |
3%
upside
| 1 | +6.1% |
0
%
| 4 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $184 |
18%
upside
| 2 | +14% |
0
%
| 29 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $44 |
51%
upside
| 1 | -0.03% |
0
%
| 29 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $8 |
259%
upside
| 1 | +26% |
0
%
| 28 Oct ‘25 1 month ago |
|
|
|
Hold
Downgraded
| – | – | 1 | +18% |
0
%
| 22 Oct ‘25 1 month ago |
|
|
|
Buy
Initiated
| $19 |
27%
upside
| 1 | +19% |
0
%
| 13 Oct ‘25 1 month ago |
|
|
|
Buy
Initiated
| $12 |
174%
upside
| 1 | -14% |
0
%
| 13 Oct ‘25 1 month ago |
|
|
|
Buy
Initiated
| $28 |
131%
upside
| 1 | +2.6% |
0
%
| 13 Oct ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $11 |
68%
upside
| 2 | +24% |
0
%
| 30 Sep ‘25 2 months ago |
|
|
|
Hold
Downgraded
| $96 |
0%
downside
| 1 | +8.7% |
0
%
| 29 Sep ‘25 2 months ago |
|
|
|
Hold
Reiterated
| – | – | 1 | -12% |
–
| 24 Sep ‘25 2 months ago |
|